Classification of HHV-6A and HHV-6B as distinct viruses
10.1007/s00705-013-1902-5 · 2014
Human Herpes Virus-6 (HHV-6) Reactivation after Hematopoietic Cell Transplant and Chimeric Antigen Receptor (CAR)- T Cell Therapy: A Shifting Landscape
10.3390/v16040498 · 2024
A population-based study of primary human herpesvirus 6 infection
10.1056/nejmoa042207 · 2005
HHV-6-Associated Neurological Disease in Children: Epidemiologic, Clinical, Diagnostic, and Treatment Considerations
10.1016/j.pediatrneurol.2019.10.004 · 2020
A systematic review and meta-analysis of HHV-6 and mortality after hematopoietic cell transplant
10.1038/s41409-024-02398-w · 2024
Viral encephalitis after hematopoietic cell transplantation: a systematic review
2023
HHV-6B detection and host gene expression implicate HHV-6B as pulmonary pathogen after hematopoietic cell transplant
10.1038/s41467-024-44828-9 · 2024
Human herpesvirus-6B reactivation is a risk factor for grades II to IV acute graft-versus-host disease after hematopoietic stem cell transplantation: a systematic review and meta-analysis
10.1016/j.bbmt.2018.04.021 · 2018
Latent human herpesvirus 6 is reactivated in CAR T cells
10.1038/s41586-023-06704-2 · 2023
Targeting herpesvirus entry complex and fusogen glycoproteins with prophylactic and therapeutic agents
10.1016/j.tim.2023.03.001 · 2023
Anti-EBV antibodies: Roles in diagnosis, pathogenesis, and antiviral therapy
2023
CD134 is a cellular receptor specific for human herpesvirus-6B entry
10.1073/pnas.1305187110 · 2013
gp96 Is Critical for both Human Herpesvirus 6A (HHV-6A) and HHV-6B Infections
2020
The structural basis of herpesvirus entry
10.1038/s41579-020-00448-w · 2021
Nectin-2 Acts as a Viral Entry Mediated Molecule That Binds to Human Herpesvirus 6B Glycoprotein B
10.3390/v14010160 · 2022
Characterization of EBV gB indicates properties of both class I and class II viral fusion proteins
10.1016/j.virol.2007.06.031 · 2007
Structure of a trimeric variant of the Epstein–Barr virus glycoprotein B
10.1073/pnas.0810530106 · 2009
HCMV gB shares structural and functional properties with gB proteins from other herpesviruses
10.1016/j.virol.2012.09.024 · 2013
Crystal structure of the human cytomegalovirus glycoprotein B
2015
Crystal structure of glycoprotein B from herpes simplex virus 1
10.1126/science.1126548 · 2006
The N-terminus of varicella-zoster virus glycoprotein B has a functional role in fusion
10.1371/journal.ppat.1008961 · 2021
Structure and Antigenicity of Kaposi’s Sarcoma‐Associated Herpesvirus Glycoprotein B
10.1002/advs.202502231 · 2025
Mutagenesis of varicella-zoster virus glycoprotein B: putative fusion loop residues are essential for viral replication, and the furin cleavage motif contributes to pathogenesis in skin tissue in vivo
10.1128/jvi.00400-09 · 2009
Cleavage of Epstein-Barr virus glycoprotein B is required for full function in cell-cell fusion with both epithelial and B cells
10.1099/vir.0.007237-0 · 2009
Glycoprotein B cleavage is important for murid herpesvirus 4 to infect myeloid cells
10.1128/jvi.00709-13 · 2013
Novel trimeric human cytomegalovirus glycoprotein B elicits a high-titer neutralizing antibody response
10.1016/j.vaccine.2018.07.056 · 2018
Structure-Function Dissection of Pseudorabies Virus Glycoprotein B Fusion Loops
10.1128/jvi.01203-17 · 2018
Structure of the Kaposi’s sarcoma-associated herpesvirus gB in post-fusion conformation
2025
Characterization of a panel of insertion mutants in human cytomegalovirus glycoprotein B
10.1128/jvi.74.3.1383-1392.2000 · 2000
Prediction of proprotein convertase cleavage sites
10.1093/protein/gzh013 · 2004
Identification of a variant A-specific neutralizing epitope on glycoprotein B (gB) of human herpesvirus-6 (HHV-6)
10.1006/viro.1996.0408 · 1996
The Neutralizing Linear Epitope of Human Herpesvirus 6A Glycoprotein B Does Not Affect Virus Infectivity
10.1128/jvi.02074-17 · 2018
Development of a highly effective combination monoclonal antibody therapy against Herpes simplex virus
10.1186/s12929-024-01045-2 · 2024
A glycoprotein B-neutralizing antibody structure at 2.8 Å uncovers a critical domain for herpesvirus fusion initiation
10.1038/s41467-020-17911-0 · 2020
Structural basis for the recognition of human cytomegalovirus glycoprotein B by a neutralizing human antibody
10.1371/journal.ppat.1004377 · 2014
Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody
10.1038/ncomms9176 · 2015
Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion
2022
Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1
10.1038/nature09420 · 2010
Nonmuscle myosin heavy chain IIb mediates herpes simplex virus 1 entry
10.1128/jvi.03079-14 · 2015
PILRalpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B
10.1016/j.cell.2008.01.043 · 2008
